Efficiency of Different Preparations of Botulinum Toxin Type A, Xeomin and Dysport, in the Management of Spastic Upper Limb After Stroke

Authors:
  • MPMarius Nicolae Popescu
    Marius Nicolae Popescu
  • CBCristina Beiu
    Cristina Beiu
  • MDMihai Cristian Dumitrascu
    Mihai Cristian Dumitrascu
  • CMClaudia Mehedintu
    Claudia Mehedintu
  • PFPatricia Delia Farcasanu
    Patricia Delia Farcasanu
  • FSFlorica Sandru
    Florica Sandru

Abstract
The present study quantifies the effect of the two botulinum toxin type A products, Xeomin and Dysport, with approval from the National Agency for Medicines and Medical Devices of Romania (ANMDMR), for the treatment of the spastic upper limb following a stroke. The results obtained in the present study show a good efficiency of using both products in the spasticity of the upper limb, and a maintenance of the results obtained for both products for a minimum period of 3 months. Also, at higher doses, the results of the study show better improvement of spasticity and upper limb function on the evaluation scales, but the local effect is not maintained for a longer period.